Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-30T15:04:43.596Z Has data issue: false hasContentIssue false
  • English
  • Français

Mania as a presenting symptom of Wilson's disease

Published online by Cambridge University Press:  24 June 2014

Prabhat Kumar Chand  and
Pratima Murthy
Prabhat Kumar Chand*
Affiliation:
Department of Psychiatry, Kasturba Medical College & Hospital, Manipal 576104, Karnataka, India
Pratima Murthy
Affiliation:
Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore 560029, Karnataka, India
*
Dr Prabhat Kumar Chand, Department of Psychiatry, Kasturba Medical College & Hospital, Manipal, Karnataka 576104, India. Tel: +91 98453 13617; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

Wilson's disease commonly presents with neurological or hepatic manifestations. When it presents with only psychiatric symptoms, or with extrapyramidal symptoms secondary to neuroleptic exposure, the diagnosis of underlying Wilson's disease may be missed.

Methods:

An 18-year-old boy presented to the psychiatric clinic with a manic syndrome and high propensity for extrapyramidal symptoms to neuroleptic. Initial examination revealed splenomegaly and pancytopenia. Subsequent detection of Kayser–Fleischer ring and typical biochemical findings confirmed the diagnosis of Wilson's disease.

Results:

While the psychiatric symptoms came under control with lithium carbonate, extrapyramidal symptoms continue to persist even after neuroleptic withdrawal. Pancytopenia thought to be due to hypersplenism persists, and patient has developed features of liver cirrhosis. Treatment with zinc and folic acid has been started, and the patient is under evaluation for treatment with penicillamine.

Conclusion:

The psychiatrist needs to recognize that Wilson's disease can uncommonly present with isolated psychiatric symptoms, including mania. Early and severe extrapyramidal symptoms secondary to neuroleptic exposure in an adolescent age group warrants a detailed evaluation to rule out underlying neuropsychiatric conditions.

Keywords

extrapyramidalmaniapancytopeniaWilson's disease
Type
Case Report
Information
Acta Neuropsychiatrica , Volume 18 , Issue 1 , February 2006 , pp. 47 - 49
Copyright
Copyright © 2006 Blackwell Munksgaard

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Roberts, EA, Schilsky, ML. A practice guideline on Wilson disease. Hepatology 2003;37: 1475–1492. CrossRefGoogle ScholarPubMed
Akil, M, Brewer, GJ. Psychiatric and behavioral abnormalities in Wilson's disease. In: Weiner, WJ, Lang, AE, eds. Advances in neurology. Vol. 65. New York: Raven Press, 1995: 171–178. Google Scholar
Wilson, SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912;34: 295–507. CrossRefGoogle Scholar
Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133: 429–435. CrossRefGoogle ScholarPubMed
Simpson, GM, Angus, JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212 (Suppl. 44):11–19. CrossRefGoogle ScholarPubMed
World Health Organization. The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. Geneva: WHO, 1992. Google ScholarPubMed
Schwartz, M, Fuchs, S, Polak, H, Sharf, B. Psychiatric manifestation in Wilson's disease. Harefuah 1993;124: 75–77. Google Scholar
Dening, TR, Berrios, GE. Wilson's disease: psychiatric symptoms in 195 cases. Arch Gen Psychiatry 1989;46: 1126–1134. CrossRefGoogle ScholarPubMed
Pandey, RS, Swamy, HS, Sreenivas, KN, John, CJ. Depression in Wilson's disease. Ind J Psychiatry 1981;23: 82–85. Google ScholarPubMed
Dobyns, WB, Goldstein, NP, Gordon, H. Clinical spectrum of Wilson's disease (Hepatolenticular degeneration). Mayo Clin Proc 1979;54: 35–42. Google Scholar
Pandey, RS, Sreenivas, KN, Patil, NM, Swamy, HS. Dopamine beta-hydroxylase inhibition in a patient with Wilson's disease and manic symptoms. Am J Psychiatry 1981;138: 1628–1629. Google Scholar